Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-12-31 Potter Stephen W Executive Vice President Grant or award +921 $3.20 $3K 14,016
2014-08-01 Potter Stephen W Executive Vice President Grant or award +6,303 12,835
2014-08-01 Potter Stephen W Executive Vice President Grant or award · Stock Option (right to purchase) +25,000 25,000
2014-06-30 Potter Stephen W Executive Vice President Grant or award +532 $5.54 $3K 6,532
2014-01-02 Potter Stephen W Executive Vice President Grant or award · Stock Option (right to purchase) +35,000 35,000
2013-07-15 Potter Stephen W Executive Vice President Grant or award · Stock Option (right to purchase) +30,000 30,000
2013-02-11 Potter Stephen W Director Grant or award +60,000 60,000
2013-02-11 Potter Stephen W Director Grant or award · Stock Option (right to purchase) +93,500 93,500

Page 1 of 1 · 8 trades